The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer
Clinical trial NCT05162196 · UNKNOWN
Trial details
- NCT number
- NCT05162196
- Sponsor
- Wuhan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-06-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.